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Intraoperative Contrast-Enhanced Ultrasound for
Brain Tumor Surgery
BACKGROUND: Contrast-enhanced ultrasound (CEUS) is a dynamic and continuous
modality that offers a real-time, direct view of vascularization patterns and tissue resistance
for many organs. Thanks to newer ultrasound contrast agents, CEUS has become a well-
established, live-imaging technique in many contexts, but it has never been used exten-
sively for brain imaging. The use of intraoperative CEUS (iCEUS) imaging in neurosurgery is
limited.
OBJECTIVE: To provide the first dynamic and continuous iCEUS evaluation of a variety
of brain lesions.
METHODS: We evaluated 71 patients undergoing iCEUS imaging in an off-label setting
while being operated on for different brain lesions; iCEUS imaging was obtained before
resecting each lesion, after intravenous injection of ultrasound contrast agent. A
semiquantitative, offline interobserver analysis was performed to visualize each brain
lesion and to characterize its perfusion features, correlated with histopathology.
RESULTS: In all cases, the brain lesion was visualized intraoperatively with iCEUS. The
afferent and efferent blood vessels were identified, allowing evaluation of the time and
features of the arterial and venous phases and facilitating the surgical strategy. iCEUS
also proved to be useful in highlighting the lesion compared with standard B-mode
imaging and showing its perfusion patterns. No adverse effects were observed.
CONCLUSION: Our study is the first large-scale implementation of iCEUS in neuro-
surgery as a dynamic and continuous real-time imaging tool for brain surgery and
provides the first iCEUS characterization of different brain neoplasms. The ability of
CEUS to highlight and characterize brain tumor will possibly provide the neurosurgeon
with important information anytime during a surgical procedure.
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maging techniques play a pivotal role during
surgical resection of brain lesions. They help
when planning a surgical strategy before the
operation, and during surgery, they indicate tumor
boundaries and the relationships of the tumor with
nearby vital structures, thus enhancing precision,
accuracy, and safety for the patients, allowing
maximal resection.1
The use of ultrasound (US) during neurosur-
gical procedures is becoming more widespread.
Multiple studies have shown that US is a valuable
tool in tumor detection during surgery.2-6
Although the quality of the gray-scale US image
before tumor resection is excellent, little infor-
mation is gained in terms of perfusion of the
lesion, even with the aid of Doppler US.4,7-10
Contrast-enhanced ultrasound (CEUS) is a rel-
atively new technique that has become progres-
sively more common because it allows, among
other things, highlighting of neoplastic lesions
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compared with the baseline US.11 CEUS is defined as low-
mechanical index real-time contrast-specific imaging.12
Contrast agents containing microbubbles have been found to give
the highest contrast.13,14 Microbubbles consist of air or inert gas
encapsulated in a layer of proteins or polymers. Microbubbles are
typically 5 mm in diameter and can therefore be transported into the
smallest capillaries and across the lungs. The passage across the lungs
allows imaging of the arterial system with a venous injection. The
pharmacokinetic of the microbubbles is quite different from that of
contrast agents used for computed tomography and MRI, which
generally diffuse in the interstitial space.15-17
Second-generation US contrast agents (UCAs) are clinically
safe and well tolerated, and CEUS is an established technique for
many organs.18
Microbubbles hit by low-acoustic-powerUSwaves start resonating
at a specific frequency according to their diameter; therefore, they
reflect US and produce US with specific harmonics. These are
detected and elaborated by the transducer through contrast-specific
algorithms (Contrast Tuned Imaging, Power Modulation, Pulse
Inversion Harmonic Imaging, Contrast Pulse Sequencing),14,15
allowing a continuous, nondestructive US scanning.16,18 This
method permits a real-time assessment of tumor contrast enhance-
ment (CE), measurement of vascularity of focal lesions during the
different dynamic phases, and analysis of tissue perfusion, as well as
online evaluation of treatment efficacy.19,20 For this reason, CEUS
seems to be an ideal method to be tested for intraoperative
visualization of brain lesions.
Only a few attempts have been made to try to visualize brain
lesions with CEUS.21-28 Moreover, all of the studies cited above
were based on preoperative, bedside, transcranial studies, being
hampered by the limitation of the bony acoustic window. Only
3 neurosurgical studies (using UCAs) have been performed
intraoperatively but on very small cohorts of patients and with
some major technical limitations.29-31 In fact, no guidelines exist
on intraoperative CEUS (iCEUS) in neurosurgery.
Themain aimof this study is to evaluate anddescribedifferent brain
pathologies by means of iCEUS compared with preliminary baseline
US and preoperative MRI. This technique, being dynamic and
continuous, allows a real-time direct view of the vascularization and
flow distribution patterns of different types of neurosurgical lesions.
METHODS
Study Design and Patient Population
We performed iCEUS in an off-label setting following the European
Federation of Societies for Ultrasound in Medicine and Biology
(EFSUMB) guidelines on CEUS.12,18,32 We evaluated patients under-
going craniotomy for brain tumor removal with image guidance using
a last-generation US system equipped with Fusion Imaging for neuro-
navigation (Esaote MyLab with Virtual Navigator, Esaote, Italy).
Patients were bearing tumorlike brain masses, which were deemed
surgically resectable, in good general status (American Society of
Anesthesiologists 1-III; Karnofsky Performance Scale. 70). All patients
were thoroughly informed about the surgical procedure, and written
consent was obtained.
Intraoperative qualitative analysis was performed comparing iCEUS
with B-mode US imaging and preoperative MRIs and correlated to
histopathology. Tumor CE was then evaluated in an offline setting
following the EFSUMB criteria on CEUS,12,18,32 performing an
interobserver, semiquantitative analysis as described below.
Equipment and Contrast Agent
ForUS-guided neuronavigation, we used a last-generationUS systemwith
a multifrequency (3-11 MHz) linear probe. The US system was equipped
with Virtual Navigator software for Fusion Imaging, allowing real-time
neuronavigation between preoperative MRI and real-time US. As a contrast
agent, we used sulfur hexafluoride-filled lipidic microbubbles, a second-
generation UCA (SonoVue, Bracco, Italy), injected intravenously as a bolus
(2.4 mL [5 mg/mL]). iCEUS scanning was performed with the Contrast
Tuned Imaging algorithm that allows real time angiosonography.
iCEUS Procedure and Data Analysis
We performed preoperative, MRI-based surgical planning with neuro-
navigation coupled toUSusing theVirtualNavigator.After bone flap removal,
a3- to11-MHz linearUSnavigatedprobe (LA332;Esaote, Italy)wasplaced in
a surgical sterile transparent plastic sheath (CIVCO), along with 5 mL US
transducing gel. The probe was placed over the dura to acquire standard
B-mode imaging scans. The lesion was identified on the 2 axes and then
measured. The lesion was also localized with standard neuronavigation and
matched with the corresponding MRI scans. iCEUS was performed with
a linear probe using low-power insonation; the consequent harmonic signals
were transduced with the Contrast Tuned Imaging algorithm. Before the
microbubble contrast agent was injected, the lesion was visualized with low-
mechanical indexB-mode imaging, alongwithhealthybrain tissue; the focusof
USwas positioned at the bottomof the lesion. The contrast agent was injected
intravenously by the anesthesiologist as a bolus (2.4mL [5mg/mL]), followed
bya flushof saline solution (10mL).The timerwas startedafterUCAinjection,
and perfusion dynamics was described starting from UCA arrival in major
vessels. A digital cine clip was registered during baseline US scanning and after
contrast agent bolus injection for 100 to 300 seconds (median, 120 seconds).
A first online intraoperative qualitative analysis was performed to assess
tumor/normal parenchyma echogenic characteristics, tumor boundaries,
and specific anatomic landmarks. All lesions were initially evaluated with
B-mode imaging, and a morphological qualitative online intraoperative
correlation between US imaging and preoperative MRI was performed
on the basis of a US real-time neuronavigation system that fused
intraoperative cerebral US with preoperative MRI. Lesions on B-mode
imaging were defined as highly hyperechoic, mildly hyperechoic, or iso-
hypoechoic compared with the surrounding normal brain parenchyma.
Other lesion characteristics were its appearance (diffuse or circumscribed),
homogeneity vs heterogeneity, presence of calcification, and cystic/
necrotic areas. Then, an online qualitative analysis of intratumor micro-
bubbles distribution and its relationships to other anatomic landmarks
was conducted. A semiquantitative offline interobserver analysis was then
performed by the first author (F.P., a neurosurgeon/certified sonologist)
and by 3 external independent radiologists (A.M., L.A., and L.S.), with
extensive experience in CEUS, to evaluate the visualization of each lesion
with iCEUS following the EFSUMB guidelines12: timing (arterial and
venous phase [time is given as range]), degree of CE (comparison with
brain parenchyma), and contrast distribution (centripetal/centrifugal
pattern, visibility of afferent/efferent vessels, intralesion vessels, cystic/
necrotic areas). All data obtained by both online and offline analyses were
correlated with the histopathology of each lesion.
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RESULTS
Weevaluated 71patients (age range, 10-76 years;mean, 50 years)
harboring different intracranial lesions (53 gliomas [16 low grade,
9 anaplastic, 28 glioblastoma], 4 meningiomas, 6 metastases, 2
ependymomas, 1 pituitary adenoma, 1 hemangioblastoma, 1
ganglioglioma, 1 central neurocytoma, 1 abscess, 1 radionecrosis;
see Table 1 for further details).
We were able to visualize all lesions both on B-mode and then
with the iCEUS technique, with a complete interobserver
agreement on both intraoperative and postoperative analyses.
Standard US B-mode and iCEUS imaging features for each case
are summarized in Table 2 and Figure 1.
We did not observe any adverse event or side effect related to the
administration of the contrast agent.
We performed a morphological qualitative interobserver online
analysis using an US-based real-time neuronavigation system that
fuses intraoperative cerebral US with preoperative MRI, simulta-
neously displaying and comparing US and MRI. In all cases, we
had great accuracy of correlation between intraoperative US
imaging and preoperative MRI, being able to visually identify,
to compare the lesions, and to easily recognize fixed anatomic
structure. We had a good morphological correspondence between
the 2 imaging modalities with good correlation and superimpo-
sition between the 2 data sets, with an error,2 mm, as shown in
Figure 2.
On standard US B-mode imaging, glioblastoma (n = 28)
appeared all hyperechoic with to brain parenchyma, with
a heterogeneous appearance composed of multiple well-defined
nodular areas and others with diffuse margins. Maximal diameter
ranged from 3 to 7 cm. All but 3 lesions had cystic/necrotic areas
(18 large and 3 with microcystic areas). Anaplastic astrocytoma
(n = 9) ranged from 4 to 7 cm in diameter. All 3 appeared
hyperechoic with a diffuse, dense texture, with some areas more
hyperechoic compared with the rest of the lesion. No cystic/
necrotic areas were noted. Low-grade gliomas (n = 16) appeared
mildly hyperechoic compared with brain parenchyma. Maximum
diameter ranged from 3 to 6 cm. All lesions had a homogeneous
texture with blurred margins at the brain/tumor interface except
for 1 oligoastrocytoma that had a discrete appearance with clear
border and the only case of ganglioglioma. Microcysts were
visible in only 2 cases. For both high- and low-grade lesions, the
tumor margins were blurred; the brain/tumor interface was not
clearly visible everywhere and was indistinguishable from
edematous brain parenchyma.
Meningiomas (n= 4), regardless of World Health Organization
grade, appeared hyperechoic, with fine granular aspects resulting
from microcystic areas. Maximum diameter ranged from 3 to
9 cm. Grade I and II meningiomas were homogeneous, whereas
anaplastic ones appeared more heterogeneous, with multiple, vast
hypoechoic areas caused by necrotic degeneration. All lesions
were clearly well demarcated from surrounding brain tissue, even
in the edematous areas.
All cerebral metastases (n = 6) were markedly hyperechoic with
a diffuse granular and heterogeneous aspect. Their diameters
ranged from 3 to 6 cm. All lesions presented cystic areas, varying
in size and calcifications. All lesions were clearly well demarcated
from brain parenchyma.
Ependymomas (n= 2) appeared as discrete nodular masses with
a diffuse, dense texture with some minute hyperechoic areas
compared with the rest of the lesion, probably resulting from
microcalcification. One measured 5 cm and the other 3 cm in
diameter. They both had multiple peripheral satellite cystic areas.
One pituitary adenoma was homogeneously hyperechoic and
had a discrete multilobular appearance with clearly demarcated
borders. Its maximum diameter was 5 cm.
One posterior fossa hemangioblastoma appeared as a nodular
hyperechoic mass surrounding a hypoechoic, heterogeneous
center with clear borders.
One frontal ganglioglioma was a round mass, hyperechoic
compared with brain parenchyma, with well-demarcated borders
and an hypo-echoic cyst in the context of the lesion.
One case of central neurocytoma was deeply located, mildly
hyperechoic, and heterogeneous with a fine multilobular aspect.
Margins were, at times, diffused within the brain parenchyma. It
measured 7 cm in diameter.
TABLE 1. Study Population Features
Cases, n Diagnosis
World Health
Organization
Grade
Gliomas
2 Pilocytic
astrocytoma
I
14 Low-grade glioma II
9 Anaplastic glioma III
28 Glioblastoma IV
Meningiomas
2 Transitional
meningioma
I
1 Atypical
meningioma
II
1 Anaplastic
meningioma
III
Other central nervous
systems primary tumors
1 Ganglioglioma I
1 Pituitary adenoma I
1 Hemangioblastoma I
2 Ependymoma II
1 Central
neurocytoma
II
Secondary brain lesions/
other
4 Lung metastasis —
1 Colon metastasis —
1 Kidney metastasis —
1 Abscess —
1 Radiation necrosis —
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TABLE 2. Results Summarya
Brain Lesion
Patients,
n
Ultrasound Imaging Features
B-Mode CEUS
Echogenicity Appearance
Cystic Areas
and/or
Necrosis
Arterial
Phase, s
CEUS
Peak, s
Venous
Phase, s
CE
Degree CE Pattern
Afferent/
Efferent
Vessels
Intralesional
Vessels
Low-grade glioma 16 Iso-
hyperechoic
Diffuse,
homogeneous
Small/
microcysts
15 20 30 Mild Diffuse, dotted,
homogeneous,
centrifugal, no
cysts
Not
visible
None
Anaplastic glioma 9 Iso-
hyperechoic
Diffuse,
homogeneous
Small/
microcysts
10 15 20-25 Mild/
high
Diffuse, dotted,
homogeneous,
centrifugal
microcysts
Visible Small
Glioblastoma 28 Hyperechoic Diffuse/
circumscribed,
heterogeneous
Large
necrotic
areas
2-3 5 10 High Nodular, highly
heterogeneous,
centripetal necrotic
areas
Visible Large
Meningioma 4 Hyperechoic Circumscribed Microcysts 5-10 15 30 High Nodular,
homogeneous/
heterogeneous.
centripetal necrotic
areas
Visible Small/large
Ganglioglioma 1 Hyperechoic Circumscribed,
homogeneous
Small/
microcysts
2-3 5 10 Mild/
high
Nodular,
homogeneous
centripetal
microcysts/
macrocysts
Visible Small
Ependymoma 2 Hyperechoic Circumscribed,
homogeneous
Small/
microcysts
5 5-10 20-25 High Nodular,
homogeneous
centripetal
microcysts/
macrocysts
Visible Small
Ctr. neurocytoma 1 Variably
hyperechoic
Nodular,
heterogeneous
None 15-20 40 30 Mild Nodular,
heterogeneous
centripetal
microcysts/
macrocysts
None None
Pituitary adenoma 1 Hyperechoic Circumscribed,
homogeneous
Microcysts 10 30 .40 Mild/
high
Diffuse, nodular,
homogeneous,
centrifugal
microcysts
None None
Hemangioblastoma 1 Variably
hyperechoic
Circumscribed,
homogeneous
None 5 10 30 High Nodular,
homogeneous,
centrifugal
microcysts/
macrocysts
Visible Small/large
(Continues)
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One case of cerebral abscess was superficial, with a thin
hyperechoic capsule surrounding a large hypo-echoic center,
measuring 5 cm in maximum diameter.
One case of radionecrosis had a homogeneous, diffuse, mildly
hyperechoic texturewithblurredmargins at thebrain/tumor interface.
Specific iCEUS patterns were observed in relation to the
different pathological entities being tested. In our series, all
neoplastic lesions showed CE, whereas 2 nonneoplastic lesions
(1 abscess and 1 radionecrosis) did not.
Glioblastomas showed a rapid CE (20-30 seconds after UCA
injection)marked by rapid arterial phase (2-3 seconds), very fast CE
peak (3-5 seconds), and chaotic transit of microbubbles within the
lesion. The arterial supply was clearly visible, showing many
macrovessels within the lesion and a typical peripheral enhancement
that moved toward the inner areas of the lesion. The venous phase
was rapid (5-10 seconds), and the venous drainage system was
diffuse, with multiple medullary veins aiming toward the periven-
tricular zone. (See Figure 3 and Video, Supplemental Digital
Content 1, http://links.lww.com/NEU/A615, which is an intra-
operative video obtained before the resection of a right parietal
glioblastoma. The screen displays dual ultrasound imaging of the
same field of view with low-mechanical index US B-mode imaging
on the left-hand side and iCEUS imaging on the right hand side of
the screen. Standard B-mode US allows identification of the region
of interest while iCEUS is performed. On the left inferior corner is
also visible a timer, which is manually started after UCA injection
and permits the evaluation of the different vascular phases. Note
how iCEUS is able to show the dynamic perfusion of the lesion,
highlighting major feeding vessels, intralesion arteries, tumor mass,
cystic/necrotic areas, and draining veins. iCEUS degree of enhance-
ment of the lesion is compared with normal brain parenchyma CE.)
CE was intense, with a persistent parenchymal phase compared with
normal brain parenchyma and a heterogeneous CE pattern
characterized by peripheral enhancement surrounding either high-
CE nodular areas or low/absent-CE, hypoperfused necrotic/cystic
areas. Tumor borders were better defined after CE than in standard
B-mode imaging.
Anaplastic astrocytoma appeared to have a slower arterial phase
compared with glioblastomas (30-40 seconds after UCA injection;
CE peak at 10-15 seconds after UCA arterial enhancement), with
a venous phase at 20 to 25 seconds. Arterial supplywas clearly visible
with a centrifugal pattern and few macrovessels within the lesion.
Venous drainagewas not clearly identifiable.Anaplastic astrocytoma
appeared to have a diffuse, progressive CE pattern, more homoge-
neous than the glioblastomas, reinforced during the parenchymal
phase. Tumor borders are less visible afterCE than in glioblastomas.
In the low-grade glioma group, the arterial phase had timing
similar to that of anaplastic astrocytomas. Nevertheless, the CE
peak was even more delayed (15-20 seconds) as well as the venous
phase (.30 seconds). The direct arterial supply and the venous
drainage were not always clear. The arterial supply was
centrifugal, and major vessels were not visible within the lesion.
Astrocytomas were mildly hyperechoic after UCA injection
compared with the brain parenchyma, and the tumor
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parenchymal phase was steady and uniform. The CE pattern was
dotted and homogeneous, with only 2 cases with microcystic
areas. In the 3 cases of oligodendroglioma, we observed features
similar to those in anaplastic astrocytoma.
Meningiomas showed an intense and rapid CE (arterial phase,
20-30 seconds after UCA injection) with even higher CE peaks in
higher grades. CE was centripetal with the major supply from the
dural attachment. All grades displayed a dense and persistent
parenchymal enhancement, being more homogeneous in grade I
meningiomas. The venous phase was delayed (.30 seconds after
UCA injection), and venous drainage was not clearly visible.
Intralesional major vessels were visible only in grade II and III
meningiomas, which also exhibited some hypodense/necrotic areas
within the lesion. Tumor borders were clearly visible in all cases.
Cerebral metastasis showed a rapid CE (20-30 seconds after
UCA injection), with a fast arterial phase (2-3 seconds) andCEpeak
(5-10 seconds). The arterial supply was centripetal, with many
macrovessels within the lesion. CE was persistent with a delayed
venous phase (.30 seconds). The venous drainage system was not
clearly visible. CE in metastases was very strong and intense with an
irregular and heterogeneous CE pattern composed of high-contrast
dense areas, macrovessels, and hypoperfused necrotic or non-
perfused cystic areas. Tumor borders were clearly defined after CE.
Both ependymoma cases were characterized by a rapid arterial
phase (5 seconds) and a very fast CE peak (5-10 seconds after UCA
arrival). The arterial supply was clearly visible and centripetal, with
many macrovessels well distinguishable within the lesion. The
venous phase was rapid (20-25 seconds), and the venous drainage
system was diffuse around the lesion. Ependymomas displayed an
irregular and heterogeneous CE pattern with homogeneous areas
alternating with hypoperfused, cystic areas.
The pituitary adenoma had a slow arterial phase (40-45 seconds
after UCA injection) and a delayed CE peak (20 seconds after UCA
arrival). The arterial supply and venous drainage were not visible,
and the CE pattern was quite regular and homogeneous. No vessels
were visible. The parenchymal phase was persistent with a slow
venous phase (.40 seconds).
One posterior fossa hemangioblastoma case displayed a rapid
wash in phase (5-10 seconds after UCA arrival) and CE peak.
Hemangioblastoma had an intense CE with a centripetal perfusion.
The CE pattern showed a peripheral homogeneous parenchymal
area surrounding a hypoperfused center (larger than what was visible
onB-modeUSonly).Nomajor vesselswere visiblewithin the lesion.
The venous phase was delayed up to 30 seconds.
Gangliogliomahad a rapid arterial phase andCEpeak (2-3 seconds
afterUCAarrival in arteries),with a homogeneous, brightCEpattern,
few small vessels within the lesion, and a hypoechoic cystic area,
superimposable to what was visible on B-mode imaging. The venous
phase was rapid as well (10-15 seconds after arterial phase).
Our case of central neurocytoma showed a delayed arterial phase
(30-40 seconds after UCA arrival) and CE peak. There was a mild
CE with multiple homogeneous nodularity. No vessels were visible
within the lesion, and the washout was delayed (.40 seconds).
Finally, 1 case of cerebral abscess and 1 radionecrosis had no CE.
The abscess had a thin, peripheral rimlikeCE area surrounding a large
necrotic center, whereas the radionecrosis remained completely
without CE (being homogeneously hyperechoic on B-mode US).
DISCUSSION
In our study, we were able to directly visualize each of the 71
different brain lesions before resection with both the B-mode and
iCEUS modalities and to surgically resect them under direct
visualization with no adverse effects.
Our study shows that iCEUS is very useful in evaluating the
location, defining the border, and depicting the vascularization and
perfusion pattern of different brain tumors. Especially in tumors
with ill-defined borders on B-modeUS such as gliomas, iCEUSwas
very helpful in highlighting the lesion and its boundaries and
possibly differentiating between tumor/edematous brain tissue.
We also demonstrate, although in a limited number of cases, the
dynamic morphological and vascular pattern of cerebral tumor,
which has only partially been shown before, demonstrating the
ability of US and iCEUS to show rapid and dynamic events such as
the arterial and venous phases of various lesions and their different
pattern and degree of enhancement.
The evaluation of different parameters such as timing of the arterial
and venous phases, peak, and intensity of CE and the presence of
intralesion vessels or cystic/necrotic areas, will possibly lead, with its
application in ahighernumber of cases, to the identificationof specific
iCEUS patterns for different cerebral lesions. This not only will
contribute to enhancing our intraoperative knowledge in regard to
tumor biology but also will lead to an iCEUS characterization of
cerebral tumors, as it has been already established by the radiological
community for other organs.12,16,18,35
The ability of iCEUS to highlight vascular structures made it
easier for the surgeon to identify the vascular peduncles, giving
further insight into the surgical strategy, facilitating vascular
deafferentation of the lesion and then its surgical removal. After
gross tumor removal, iCEUSmight also be used to highlight tumor
remnants, thus maximizing resection and avoiding neurological
sequelae resulting from damaged healthy brain tissue.
FIGURE 1. A comprehensive panel correlating magnetic resonance imaging (MRI) and ultrasound (US) appearance
(both B-mode and contrast-enhanced US [CEUS]) of different brain lesions grouped by pathology (A, gliomas; B, other
tumors; C, meningiomas; D, metastases; E, radiation necrosis; and F, cerebral abscess). Every brain lesion is highlighted
on a contrast-enhanced MRI (arrow). Note how preoperative MRI, B-mode, and CEUS appearances correlate (normal
and pathological vessels look orange in CEUS; nonvascularized/cystic/necrotic areas are black [star]). a., astrocytoma;
aden., adenoma; g., glioma; WHO, World Health Organization.
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Quite a few transcranial CEUS bedside studies have been
performed on cerebrovascular patients to asses brain perfusion,
extent of stroke, and response to stroke therapy24,36,37; on the
other hand, only a few studies have investigated the role of iCEUS
in highlighting cerebral tumors.21,22,27 In these studies, the authors
showed the possibility of visualizing brain lesions with CEUS.
Transcranial US is a well-established technique, but because of the
cranial vault, it has a major limitation for brain tumor detection. Even
FIGURE 2. Virtual navigation unit screenshot used for intraoperative ultrasound (US) and preoperative magnetic resonance
imaging (MRI) comparison, showing a left frontal mesial low-grade glioma (World Health Organization grade II). In the top
panel, it is possible to visualize the MRI-based coronal visualization of the lesion in the right portion of the screen. The left portion
of the screen shows the intraoperative US imaging, which is correlated to the navigated MRI. In the inferior portion of the screen,
the different planes (sagittal, coronal, axial, plane of probe) are depicted. In the inferior panel, the 2 imaging modalities have been
overlapped to evaluate the degree of correlation of the system and to evaluate and compare the different features of the lesion on
both modalities.
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at the level of the temporal bone, despite its limited thickness, it is
necessary to use a low-frequency insonation that does not allow high
resolution and detailed evaluation of the brain parenchyma.
Moreover, the use of a limited and fixed bone window does not
allow the visualization of all kinds of lesions, and it is strongly
dependent on the site of the lesion.22,23,38,39 Harrer et al,22,23,39 by
using preoperative CEUS, were able to distinguish some brain lesions
from the brain parenchyma and to partially characterize different
cerebral lesions. In another study, Vicenzini et al21 obtained time
intensity/curves using dedicated software. However, in this series, the
study population was small. In fact, time-intensity curves need very
large cohorts to obtain a statistically significant result, as well as
validation study for quantitative analysis.40 Nevertheless, these studies
demonstrate the increasing interest in CEUS and brain tumors.
iCEUS has been undertaken in an intraoperative setting for brain
tumor surgery only a few times, obtaining direct tumor visualization
but with some limitations.29-31 Kanno et al29 analyzed 40 brain
tumors using a first-generation contrast agent, obtaining only
frame-by-frame imaging. Engelhardt et al30 made a step forward,
performing iCEUS during brain tumor removal using a second-
generation contrast agent with a specific algorithm and performing
offline time-intensity curves, but on a very small and homogeneous
cohort of patients (7 glioblastoma patients). Indeed, to provide
statistically relevant results with time-intensity curves, they should
be performed on a large sample size.41 He et al31 intraoperatively
evaluated 29 brain tumors (22 gliomas and 7 meningiomas) using
iCEUS technique. They used a phased-array probe with low
frequency and a vast view field (as used in transcranial Doppler),
and the US imaging was performed in power Doppler modality
instead of with a contrast-specific algorithm, dramatically reducing
both US spatial resolution and definition.
Another study by Wang et al42 (only the abstract is available)
evaluated the feasibility and value of intraoperative contrast-
enhanced US in different pathological grades of glioma appar-
ently without obtaining iCEUS characterization for these lesions.
Our findings also showed specific iCEUS features for each
different kind of brain lesion, which might suggest a specific iCEUS
pattern related to each different lesion. In glioblastomas, we found
a heterogeneousCEUS patternwith rapid arterial and venous phases
and high CE compared with brain parenchyma, and in all cases, it
was always possible to visualize major arterial feeders. We also found
almost invariably venous drainage through the periventricular
medullary veins. The lesion was always well demarcated from brain
parenchyma, and in some cases, iCEUS was able to show tumor
remnants. Complete tumor demarcation was not always obtainable
in anaplastic astrocytoma, even though a marked CE was clearly
visible comparedwithbrain parenchyma.Five anaplastic gliomas had
been presurgically considered low-grade gliomas on the basis ofMRI
findings. In these cases, iCEUS showed a denser pattern with higher
CE areas, probably expression of anaplastic foci within otherwise
low-grade lesions.
Surprisingly, we found a subtle but clearly visible CE also in
low-grade gliomas, which usually lack CE on MRI. In low-grade
gliomas, iCEUS showed a scattered and dotted CE with slow
vascular phases in all cases, even if borders were not always clearly
distinguishable from healthy brain tissue.
For meningeal and other extra-axial vascular lesions such as
hemangioblastoma, iCEUS showed a clear delineation of the lesion.
Visualization of the arterial feeders and venous drainage is very
helpful in planning the surgical strategy to progressively devascu-
larize the lesion, avoiding profuse bleeding. In meningioma cases,
however, complete lesion visualization could be impaired because of
dural coagulation before CEUS scanning, thus reducing tumor
perfusion. iCEUS confirmed the nonperfusion of avascular lesions
such as abscess and radionecrosis, giving further assistance in
differentiating these lesions fromother lesions such as glioblastomas.
FIGURE 3. Time frame of how a glioblastoma (right parietal) is visualized by ultrasound (both B-mode and contrast-enhanced ultrasound; top row), along with a schematic
representation of it (bottom row). Note how the microbubble contrast medium allows the neurosurgeon to visualize the feeding artery (full arrowhead; A), the arterial phase, and
the tumor parenchyma (B and C; the empty arrowhead points at the secondary arteries, and the star shows the cystic/necrotic areas), followed by the venous phase and the
draining veins (arrow) of the lesion (D and E).
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Furthermore, US is a readily repeatable, dynamic, inexpensive
procedure that can beperformed any time for a potentially unlimited
number of times during surgery.43 Other intraoperative imaging
techniques such as intraoperative MRI and 5-aminolevulinic acid
(5-ALA) are also able to highlight brain lesions but with some
limitations compared with iCEUS. IntraoperativeMRI, in addition
to being expensive, requires the surgical procedure to stop during
the acquisition phase, making the procedure considerably time-
consuming, whereas iCEUS imaging procedure takes a fewminutes
when properly conducted. For further accuracy and orientation,
our US device is equipped with virtual navigation software that
couples in real time the preoperative MRI with dynamic imaging
provided with iCEUS.44 On the other hand, fluorescence-guided
surgery such as that obtained with 5-ALA is an excellent method
for intraoperative tumor visualization, but it can be adopted only in
high-grade gliomas, whereas UCAs are, in our experience, able to
visualize all kinds of brain lesions. Another major distinction
depends on how tumor tissue is visualized. iCEUS shows on
a screen a measurable section of the lesion before and at any given
time during tumor resection, providing the surgeon with important
information such as the on-site tumor morphology, the tumor
relationships with anatomic landmark, and the thickness of tumor
remnants during tissue resection. On the contrary, 5-ALA shows
only the tumor surface. As a consequence, drawbacks in 5-ALA
visualization might be due to neoplastic tissue hidden by healthy,
nonfluorescent tissue. Furthermore, not all glioblastoma cells
properly uptake 5-ALA, therefore reducing tumor visualization.45
Limitations
One major limitation of the CEUS technique is that individual
imaging sections are applied with US, analyzing 1 portion of the
lesion at a time. It is therefore mandatory to accurately scan the
lesion in B-mode and color Doppler imaging before performing
iCEUS to evaluate the more significant portion of the lesion and to
obtain as much information as possible in regard to the timing.
Offline analysis during surgery could be performed, allowing amore
accurate interobserver analysis, even though it is difficult to share
and transmit the whole set of information between all performers.
However, a correlation between iCEUS and preoperative MRI
(T1-weighted gadolinium) presents some major obstacles when
comparing the degree of CE between the 2 techniques. In fact,
microbubbles are purely intravascular, whereas MRI contrast agent
is mainly interstitial. Furthermore, CEUS is a dynamic perfusion
imaging, and MRI is static.33,34 We agree that this is a very
interesting aspect, and further studies are needed in the future.
Care must also be taken in the preparation of UCA and its
administration. Instructions for preparation must be followed
accurately by the nurse anesthetist, and UCA injection has to be
strictly synchronized with the start of the timer to achieve an
accurate calculation of UCA transit time. To obviate such
drawbacks, according to the EFSUMB guidelines, it is advisable
that the surgeonwho performs intraoperativeUS be trained for US
and especially for CEUS, as in our case.12,18,39 Further studies are
needed to evaluate the role of CEUS in tumor resection.
CONCLUSION
Our study is the first implementation in neurosurgery of iCEUS
in a relatively large-scale setting.We found that iCEUS is a safe and
fast intraoperative technique that completes and integrates the
information obtained with standard B-mode and color Doppler
imaging, providing dynamic and continuous real-time imaging
and characterization of several brain lesions. Moreover, defining
the paradigm of iCEUS adds valuable anatomic and biological
information such as vascularization, microcirculation, and tissue
perfusion dynamic, which will possibly provide further insights
into the pathology of brain tumors, especially if integrated with
other US modalities such as color Doppler and elastosonography.
Performing iCEUS before tumor removal might help the
surgeon tailor the approach to the lesion, highlighting the lesion,
clarifying between tumor and edematous brain tissue, and showing
afferent and efferent vessels and hyperperfused areas, thus possibly
modifying the intraoperative surgical strategy.
Further studies are needed to evaluate the role of iCEUS in
highlighting tumor remnants after gross tumor removal, especially
in high-grade lesions, thus maximizing resection and avoiding
neurological sequelae.
In our experience, iCEUS has proven to be a simple and relatively
inexpensive technique (especially compared with other intraoper-
ative techniques such as 5-ALA and intraoperative MRI), and the
expected results will potentially integrate scientific excellence and
lead to better treatment for brain tumor patients, resulting in further
understanding of and exploitation in the field of brain surgery.
Disclosure
The authors have no personal financial or institutional interest in any of the
drugs, materials, or devices described in this article.
REFERENCES
1. Upadhyay UM, Golby AJ. Role of pre- and intraoperative imaging and
neuronavigation in neurosurgery. Expert Rev Med Devices. 2008;5(1):65-73.
2. Sosna J, Barth MM, Kruskal JB, Kane RA. Intraoperative sonography for
neurosurgery. J Ultrasound Med. 2005;24(12):1671-1682.
3. Unsgaard G, Gronningsaeter A, Ommedal S, Nagelhus Hernes TA. Brain
operations guided by real-time two-dimensional ultrasound: new possibilities as
a result of improved image quality. Neurosurgery. 2002;51(2):402-411; discussion
411-412.
4. Selbekk T, Jakola AS, Solheim O, et al. Ultrasound imaging in neurosurgery:
approaches to minimize surgically induced image artefacts for improved resection
control. Acta Neurochir (Wien). 2013;155(6):973-980.
5. Woydt M, Krone A, Becker G, Schmidt K, Roggendorf W, Roosen K. Correlation
of intra-operative ultrasound with histopathologic findings after tumour resection
in supratentorial gliomas: a method to improve gross total tumour resection. Acta
Neurochir (Wien). 1996;138(12):1391-1398.
6. Woydt M, Vince GH, Krauss J, Krone A, Soerensen N, Roosen K. New
ultrasound techniques and their application in neurosurgical intra-operative
sonography. Neurol Res. 2001;23(7):697-705.
7. Lindseth F, Lovstakken L, Rygh OM, Tangen GA, Torp H, Unsgaard G. Blood
flow imaging: an angle-independent ultrasound modality for intraoperative
assessment of flow dynamics in neurovascular surgery. Neurosurgery. 2009;65
(suppl 6):149-157; discussion 157.
8. Mirzai S, Samii M. Current status and future challenges in cerebral blood flow
mapping in intracranial tumors. Keio J Med. 2000;49(suppl 1):A16-A24.
INTRAOPERATIVE CEUS FOR BRAIN SURGERY
NEUROSURGERY VOLUME 74 | NUMBER 5 | MAY 2014 | 551
Downloaded from https://academic.oup.com/neurosurgery/article-abstract/74/5/542/2447687
by C Besta Biblioteca Centrale user
on 23 August 2018
9. Becker G, Perez J, Krone A, et al. Transcranial color-coded real-time sonography in
the evaluation of intracranial neoplasms and arteriovenous malformations.
Neurosurgery. 1992;31(3):420-428.
10. Wang J, Liu X, Hou WH, et al. The relationship between intra-operative
ultrasonography and pathological grade in cerebral glioma. J Int Med Res. 2008;36
(6):1426-1434.
11. Correas JM, Bridal L, Lesavre A, Méjean A, Claudon M, Hélénon O. Ultrasound
contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol.
2001;11(8):1316-1328.
12. Piscaglia F, Nolsøe C, Dietrich CF, et al. The EFSUMB guidelines and
recommendations on the clinical practice of contrast enhanced ultrasound (CEUS):
update 2011 on non-hepatic applications. Ultraschall Med. 2012;33(1):33-59.
13. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice
recommendations for contrast enhanced ultrasound (CEUS): update 2008.
Ultraschall Med. 2008;29(1):28-44.
14. Mostbeck G. “Hot topics” in contrast-enhanced ultrasound (CEUS): introduc-
tion. Ultraschall Med. 2012;33(suppl 1):S1-S2.
15. Gibbs V, Cole D, Sassano A. Ultrasound Physics and Technology. Edinburgh, UK:
Elsevier Health Sciences; 2009:111-119.
16. Quaia E. Assessment of tissue perfusion by contrast-enhanced ultrasound. Eur
Radiol. 2011;21(3):604-615.
17. Martegani A, Aiani L, Borghi C. The use of contrast-enhanced ultrasound in large
vessels. Eur Radiol. 2004;14(suppl 8):P73-P86.
18. Sidhu PS, Choi BI, Nielsen MB. The EFSUMB guidelines on the non-hepatic
clinical applications of contrast enhanced ultrasound (CEUS): a new dawn for the
escalating use of this ubiquitous technique. Ultraschall Med. 2012;33(1):5-7.
19. Lassau N, Chami L, Chebil M, et al. Dynamic contrast-enhanced ultrasonography
(DCE-US) and anti-angiogenic treatments. Discov Med. 2011;11(56):18-24.
20. Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and monitoring of
radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur
J Radiol. 2004;51(suppl):S19-S23.
21. Vicenzini E, Delfini R, Magri F, et al. Semiquantitative human cerebral perfusion
assessment with ultrasound in brain space-occupying lesions: preliminary data.
J Ultrasound Med. 2008;27(5):685-692.
22. Harrer JU, Möller-Hartmann W, Oertel MF, Klötzsch C. Perfusion imaging of
high-grade gliomas: a comparison between contrast harmonic and magnetic
resonance imaging. Technical note. J Neurosurg. 2004;101(4):700-703.
23. Harrer JU, Hornen S, Oertel MF, Stracke CP, Klötzsch C. Comparison of
perfusion harmonic imaging and perfusion MR imaging for the assessment of
microvascular characteristics in brain tumors. Ultraschall Med. 2008;29(1):45-52.
24. Seidel G, Meyer K. Harmonic imaging: a new method for the sonographic
assessment of cerebral perfusion. Eur J Ultrasound. 2001;14(2-3):103-113.
25. Meairs S, Daffertshofer M, Neff W, Eschenfelder C, Hennerici M. Pulse-inversion
contrast harmonic imaging: ultrasonographic assessment of cerebral perfusion.
Lancet. 2000;355(9203):550-551.
26. Federlein J, Postert T, Meves S, Weber S, Przuntek H, Büttner T. Ultrasonic
evaluation of pathological brain perfusion in acute stroke using second harmonic
imaging. J Neurol Neurosurg Psychiatry. 2000;69(5):616-622.
27. Bogdahn U, Fröhlich T, Becker G, et al. Vascularization of primary central
nervous system tumors: detection with contrast-enhanced transcranial color-coded
real-time sonography. Radiology. 1994;192(1):141-148.
28. Becker G, Winkler J, Bogdahn U. Transcranial color-coded real time sonography
in adults. Part 2: cerebral hemorrhage and tumors [in German]. Ultraschall Med.
1991;12(5):211-217.
29. Kanno H, Ozawa Y, Sakata K, et al. Intraoperative power Doppler ultrasonography with
a contrast-enhancing agent for intracranial tumors. J Neurosurg. 2005;102(2):295-301.
30. Engelhardt M, Hansen C, Eyding J, et al. Feasibility of contrast-enhanced
sonography during resection of cerebral tumours: initial results of a prospective
study. Ultrasound Med Biol. 2007;33(4):571-575.
31. He W, Jiang XQ, Wang S, et al. Intraoperative contrast-enhanced ultrasound for
brain tumors. Clin Imaging. 2008;32(6):419-424.
32. Bamber J, Cosgrove D, Dietrich CF, et al. EFSUMB guidelines and recom-
mendations on the clinical use of ultrasound elastography, part 1: basic principles
and technology. Ultraschall Med. 2013;34(2):169-184.
33. Whittle IR. Surgery for gliomas. Curr Opin Neurol. 2002;15(6):663-669.
34. Willems PW, TaphoornMJ, Burger H, Berkelbach van der Sprenkel JW, Tulleken CA.
Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing
tumors: a randomized controlled trial. J Neurosurg. 2006;104(3):360-368.
35. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with
contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast
agent: diagnostic performance and confidence. Radiology. 2004;232(2):420-430.
36. Bartels E, Henning S, Wellmer A, Giraldo-Velásquez M, Kermer P. Evaluation of
cerebral perfusion deficit in stroke patients using new transcranial contrast imaging
CPS technology: preliminary results. Ultraschall Med. 2005;26(6):478-486.
37. Kern R, Perren F, Schoeneberger K, Gass A, Hennerici M, Meairs S. Ultrasound
microbubble destruction imaging in acute middle cerebral artery stroke. Stroke.
2004;35(7):1665-1670.
38. van Leyen K, Klötzsch C, Harrer JU. Brain tumor imaging with transcranial
sonography: state of the art and review of the literature. Ultraschall Med. 2011;32
(6):572-581.
39. Harrer JU, Mayfrank L, Mull M, Klötzsch C. Second harmonic imaging: a new
ultrasound technique to assess human brain tumour perfusion. J Neurol Neurosurg
Psychiatry. 2003;74(3):333-338.
40. Leen E, Averkiou M, Arditi M, et al. Dynamic contrast enhanced ultrasound
assessment of the vascular effects of novel therapeutics in early stage trials. Eur
Radiol. 2012;22(7):1442-1450.
41. Giangregorio F, Bertone A, Fanigliulo L, et al. Predictive value of time-intensity
curves obtained with contrast-enhanced ultrasonography (CEUS) in the follow-up
of 30 patients with Crohn’s disease. J Ultrasound. 2009;12(4):151-159.
42. Wang YQ, Yu SQ, Wang JS, et al. Application of intraoperative contrast-enhanced
ultrasound in different pathological grades of glioma [in Chinese]. Zhonghua Yi
Xue Za Zhi. 2012;92(21):1495-1497.
43. Romanini L, Passamonti M, Aiani L, et al. Economic assessment of contrast-
enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian
experience. Eur Radiol. 2007;17(suppl 6):F99-F106.
44. Busse H, Schmitgen A, Trantakis C, Schober R, Kahn T, Moche M. Advanced
approach for intraoperative MRI guidance and potential benefit for neurosurgical
applications. J Magn Reson Imaging. 2006;24(1):140-151.
45. Stummer W, Novotny A, Stepp H, Goetz C, Bise K, Reulen HJ. Fluorescence-
guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-
induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg.
2000;93(6):1003-1013.
Supplemental digital content is available for this article. Direct URL citations appear in
the printed text and are provided in the HTML and PDF versions of this article on the
journal’s Web site (www.neurosurgery-online.com).
Acknowledgments
The authors would like to thank Mrs Caroline King, DipArch, for her kind
advice in revising the manuscript and Mr Luca Lodigiani for his technical support.
COMMENT
T his is an important article dealing with contrast-enhanced ultrasoundin brain tumor surgery. I believe that this technique should be further
developed to offer neurosurgeons an extremely fast and rather cost-
effective imaging technology.
It has to be investigated whether the combination with intraoperative
magnetic resonance imaging at the end of surgery or the standalone
application can detect tumor remnants.
Martin Scholz
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